Decrease in Switches to ‘Unsafe’ Proton Pump Inhibitors After Communications About Interactions with Clopidogrel-Reference-Cited by-同舟云学术

Decrease in Switches to ‘Unsafe’ Proton Pump Inhibitors After Communications About Interactions with Clopidogrel

Published:2017-05-25 Issue:8 Volume:37 Page:787-794
ISSN:1173-2563
Container-title:Clinical Drug Investigation
language:en
Short-container-title:Clin Drug Investig

Author:

Kruik-Kollöffel Willemien J.^ORCID,van der Palen Job,van Herk-Sukel Myrthe P. P.^ORCID,Kruik H. Joost,Movig Kris L. L.

Funder

None

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/article/10.1007/s40261-017-0536-x/fulltext.html

Reference26 articles.

1. Gilard M, Arnaud B, Cornily JC, et al. Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study. J Am Coll Cardiol. 2008;51:256–60.

2. Focks JJ, Brouwer MA, Van Oijen MG, et al. Concomitant use of clopidogrel and proton pump inhibitors: impact on platelet function and clinical outcome—a systematic review. Heart. 2013;99:520–7. doi: 10.1136/heartjnl-2012-302371 .

3. Kruik-Kollöffel WJ, Van der Palen J, Kruik HJ, et al. Prescription behavior for gastroprotective drugs in new users as a result of communications regarding clopidogrel—proton pump inhibitor interaction. Pharm Res Perspect. 2016;4(4):e00242. doi: 10.1002/prp2.242 .

4. Reber KC, Piening S, Wieringa JE, et al. When direct health-care professional communications have an impact on inappropriate and unsafe use of medicines. Clin Pharmacol Ther. 2013;93:360–5. doi: 10.1038/clpt.2012.262 .

5. World Health Organization (WHO). Adherence to long-term therapies: evidence for action. Geneva; January 2003. http://apps.who.int/iris/bitstream/10665/42682/1/9241545992.pdf . Accessed 4 Feb 2017.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clopidogrel safety communication impact on histamine‐2 receptor antagonist and proton‐pump inhibitor use trends;Journal of Pharmaceutical Health Services Research;2019-07-19

2. Low Levels of High-Density Lipoprotein Cholesterol Are Linked to Impaired Clopidogrel-Mediated Platelet Inhibition;Angiology;2018-02-26